Cell viability effects of triamcinolone acetonide and preservative vehicle formulations
- 19 January 2006
- journal article
- other
- Published by BMJ in British Journal of Ophthalmology
- Vol. 90 (2) , 233-236
- https://doi.org/10.1136/bjo.2005.076190
Abstract
Aim: To assess the effect of triamcinolone acetonide and preservative vehicle formulations on human retinal pigment epithelium (ARPE19) cells over a range of concentrations. Methods: Triamcinolone acetonide, in its trade and preservative free formulations, along with the preservative vehicle were added to ARPE19 cell cultures in various concentrations (0.01–1.0 mg/ml). Cell viability was assessed using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay at day 5 after exposure. Functionality of the cultured ARPE19 cell line was confirmed by exposure to a previously characterised toxic agent, tamoxifen. Results: The ARPE19 cell line behaved as predicted with exposure to tamoxifen. All formulations caused significant reductions in ARPE19 cell viability at the highest concentrations (1.0 mg/ml for triamcinolone preparations and undiluted vehicle). Cell viability was reduced to the greatest degree in trade formulation triamcinolone, less so by the vehicle, and least by preservative free triamcinolone. At lower concentrations no significant effect on cell viability was observed, although cell viability was found to be inversely proportional to increasing concentration of all tested reagents Conclusions: Both the trade and preservative free formulations of triamcinolone acetonide as well as the vehicle result in cell loss at in vitro concentrations of 1 mg/ml. Although this represents theoretical vitreous concentrations achieved with current widespread therapeutic use it probably does not indicate the actual exposure of cells in their biological milieu. That cell viability was reduced most in the trade formulation suggests a possible potentiated inhibitory toxic effect of triamcinolone acetonide and vehicle at higher concentrations.Keywords
This publication has 16 references indexed in Scilit:
- Diffuse diabetic macular oedema treated by intravitreal triamcinolone acetonide: a comparative, non-randomised studyBritish Journal of Ophthalmology, 2005
- Branch retinal vein occlusion treated by intravitreal triamcinolone acetonideEye, 2004
- The toxic and stress responses of cultured human retinal pigment epithelium (ARPE19) and human glial cells (SVG) in the presence of triamcinolone.Investigative Opthalmology & Visual Science, 2003
- INFECTIOUS AND PRESUMED NONINFECTIOUS ENDOPHTHALMITIS AFTER INTRAVITREAL TRIAMCINOLONE ACETONIDE INJECTIONRetina, 2003
- Intravitreal crystalline triamcinolone acetonide as an additional tool in pars plana vitrectomy for complicated proliferative vitreoretinopathy?Acta Ophthalmologica Scandinavica, 2003
- A Comparative Study of Effects of Antiproliferative Drugs on Human Retinal Pigment Epithelial Cells in VitroJournal of Ocular Pharmacology and Therapeutics, 2002
- Evaluation of the cytotoxicity of selected systemic and intravitreally dosed drugs in the cultures of human retinal pigment epithelial cell line and of pig primary retinal pigment epithelial cellsToxicology in Vitro, 2001
- ARPE-19, A Human Retinal Pigment Epithelial Cell Line with Differentiated PropertiesExperimental Eye Research, 1996
- Experimental and Clinical Observations of the Intraocular Toxicity of Commercial Corticosteroid PreparationsAmerican Journal of Ophthalmology, 1986
- The Lack of Toxicity of Intravitreally Administered Triamcinolone AcetonideAmerican Journal of Ophthalmology, 1981